The global intrauterine insemination devices market is expected to be valued at USD 40.5 million in 2023 and reach a valuation of USD 57.5 million by 2033. The demand for intrauterine insemination devices is estimated to grow at a steady 3.6% CAGR, with the United Kingdom, the United States, China, and India emerging as critical producers.
The intrauterine insemination devices market is experiencing significant growth due to several factors. Firstly, the rise in couples struggling with infertility has increased the demand for assisted reproductive technology (ART) treatments such as Intrauterine Insemination (IUI). With the increasing incidences of infertility, the demand for intrauterine insemination devices is projected to grow at a rapid pace in the coming years.
Technological advancements have played a significant role in driving growth in the IUI devices market. The development of advanced IUI devices with better ergonomic designs, higher accuracy rates, and improved functionality has led to increased adoption of IUI as a fertility treatment option. These advancements have enabled medical professionals to perform IUI procedures more efficiently and with greater precision, resulting in better outcomes for patients.
Moreover, there has been a growing awareness of fertility treatments and options among the public. With increased education about the benefits of IUI as a less invasive and lower-cost fertility treatment option compared to IVF devices, there has been a surge in demand for intrauterine insemination devices. This trend is expected to continue as more individuals become aware of the benefits of IUI and seek out this treatment option.
The growing acceptance of non-traditional families and the availability of sperm donors has increased the number of single women and same-sex couples seeking fertility treatments, including IUI. These individuals often require the use of donor sperm, which is inserted into the uterus during an IUI procedure. This trend is particularly prevalent in countries where laws and cultural attitudes towards non-traditional families have become more accepting, increasing demand for intrauterine insemination devices.
| Attributes | Details |
|---|---|
| Intrauterine Insemination Devices Market CAGR (2023 to 2033) | 3.6% |
| Intrauterine Insemination Devices Market Size (2023) | USD 40.5 million |
| Intrauterine Insemination Devices Market Size (2033) | USD 57.5 million |
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
| Particulars | Details |
|---|---|
| H1, 2021 | 3.81% |
| H1, 2022 Projected | 3.76% |
| H1, 2022 Outlook | 3.26% |
| BPS Change - H1, 2022 (O) - H1, 2022 (P) | (-) 50 ↓ |
| BPS Change - H1, 2022 (O) - H1, 2021 | (-) 55 ↓ |
As per Future Market Insights' analysis, the global intrauterine insemination devices market faced a decline of 55 Basis Point Share (BPS) in H1-2022 compared to the previous year. The COVID-19 pandemic has caused temporary lockdown restrictions and supply chain disruptions, leading to a drop in BPS values. Additionally, the initial stages of the pandemic saw a decline in procedure adoption rates.
Despite these setbacks, studies have proven that intrauterine insemination devices are more efficient than in-vitro fertilization and prevent limitations of assisted reproductive technology, such as infection spread and standard procedure accuracy. This is why the market is expected to grow in the forecasted years.
To aid in this growth, critical developments in the market include the development of automated systems for sperm preparation for intrauterine insemination. Furthermore, several emerging FemTech companies are providing market-specific products, opening opportunities for developing intrauterine insemination devices in the market.
The sale of intrauterine insemination devices expanded at a CAGR of 3.5% from 2018 to 2022, owing to the increased adoption of advanced intrauterine insemination devices.
Short-term Outlook: Minimally invasive procedures, including IUI, are becoming increasingly popular due to their ability to reduce the risk of complications, shorten hospital stays, and reduce recovery times. This trend is expected to boost the growth of the IUI devices market.
Medium-term Outlook: The soft-flexible tube is the most recent advancement in intrauterine insemination catheter technology, which improves patient comfort and can be modified to fit the patient's body while delivering spermatozoa. As a result, continuous development improves the procedure's success rate and is expected to grow the intrauterine insemination devices market.
Long-term Outlook: The demand for fertility therapeutics such as intrauterine insemination and in-vitro fertilization is predicted to rise because of several government initiatives and campaigns to improve maternal health. One of the primary driving factors for the market expansion of intrauterine insemination devices is favorable government regulations. Compared to the previous decade, government aid in several developing countries has enhanced fertility therapies within such regions.
These factors cumulatively assist with the development and growth in the adoption of intrauterine insemination devices globally, and the market is expected to display a growing trend in sales metrics over the analyzed period of forecast.
Principal Consultant
China and India have a large population base with a higher rate of infertility than other countries. According to recent National Family Health Survey data from 2021, India's national total fertility rate has dropped below 2.0. However, as healthcare facilities increase in these regions, the demand for intrauterine insemination devices is expected to grow in the coming years.
Advancements in technology and a rising prevalence of infertility disorders give manufacturers and providers new opportunities. Key players are investing in augmented product development that is simple to use and provides quick results, projecting growth prospects for the intrauterine insemination devices market.
In the United States, roughly 448 reported fertility clinics in 2018 performed over 300,000 assisted reproductive treatments, per the United States CDC.
In February 2020, the Indian government took measures to regulate clinics providing safe and ethical ART services to infertile couples, approving the Assistive Reproductive Technology Regulation Bill 2020.
Public health foundations have raised awareness about infertility, leading to increased responsiveness and potentially driving a surge in demand for intrauterine insemination devices in the global market. This is expected to attract important players with new products and devices to enter the market.
The intrauterine insemination procedure costs less than other invasive fertility treatments but has additional costs associated with them, increasing the total treatment cost. In the United States, one intrauterine insemination cycle costs an average of USD 350 - USD 450, where the additional prices include: blood work, ultrasound, and medication, which can lead to a total cost of USD 1,000.
High costs associated with the procedures for intrauterine insemination thus burden the associated clients and act as impeding forces impacting the growth of the overall intrauterine insemination devices market.
The success rate of intrauterine insemination varies from patient to patient, depending on age and other factors. Because intrauterine insemination is less invasive than other reproductive interventions, it has a lower success rate than other fertility treatments.
The average success rate of intrauterine insemination among females under 35 is around 13%, whereas the success rate of in-vitro fertilization treatment jumps to 54% for the same patients. This projects restrictive growth for the global intrauterine insemination devices market.
In the coming decade, the risks associated with intrauterine insemination may threaten the market growth for intrauterine insemination devices. Intrauterine insemination can lead to possible infections as a side effect of the procedure. As a possible cause of the combined effect of the intrauterine insemination procedure and fertility medications, resulting in multiple pregnancies is an imperative risk factor.
The placement of a catheter can also cause minor vaginal bleeding. The presence of alternative infertility treatment alternatives, advances in assisted reproductive technology, and increased research and development activities have resulted in the development of several fertility treatment options.
In-vitro fertilization, intrafallopian gamete transfer, frozen embryo transfer, and intrafallopian zygote transfer are some of the reproductive treatments available. As a result, alternative infertility treatment options may hamper the market for intrauterine insemination devices.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
| CAGR (2023 to 2033) | 4.1% |
|---|---|
| Market Valuation (2033) | USD 8.7 million |
The United States is the most lucrative market for intrauterine insemination devices, thanks to breakthroughs and innovations in reproductive treatments such as intrauterine insemination and in-vitro fertilization. These developments have increased the success rates of assisted reproductive technologies among fertile and infertile couples.
As per the Centers for Disease Control and Prevention (CDC), 1.7 percent of children born in the United States in 2017 received assisted reproductive technology, which increased to 1.9 percent of infants in 2018 due to technological advancements over the year. This highlights the growing importance of intrauterine insemination devices in assisted reproductive technology in the United States.
| CAGR (2023 to 2033) | 4.8% |
|---|---|
| Market Valuation (2033) | USD 1.2 million |
There is a high demand for fertility treatments in Germany due to several factors, such as delayed childbearing, rising infertility rates, and changing lifestyles. This has led to an increased demand for intrauterine insemination devices as a less invasive and expensive option for couples struggling to conceive.
Germany's well-developed healthcare system provides good coverage for fertility treatments, including IUI. This has encouraged more people to seek fertility treatments, which has resulted in a larger market for IUI devices.
Japan held a 63.1% share in the East Asia intrauterine insemination devices market in 2021, and the share is projected to increase during the forecast period. Because of its vast population, Japan dominates the intrauterine insemination device market in East Asia, and artificial insemination costs are relatively low.
East Asia's dominance in the intrauterine insemination sector is partly attributed to the growing regional enterprises and government initiatives that encourage fertility therapy. Medical tourism is also becoming more popular within the region for fertility treatments.
| CAGR (2023 to 2033) | 3.3% |
|---|---|
| Market Valuation (2033) | USD 5.5 million |
The demand for intrauterine insemination devices in China has risen due to the growing infertility cases in the country. The market for intrauterine insemination devices is expanding rapidly to cater to the diverse spectrum of customers.
The increasing investment in IVF clinics is expected to expand the support market for upgraded healthcare infrastructure in both public and private sectors, further driving the growth of the market for intrauterine insemination devices in China. As a result, China is projected to be a growing market for intrauterine insemination devices from 2023 to 2033.
Intrauterine insemination media/sperm wash projects a lucrative growth till the end of the forecast period. Many factors influence the success of intrauterine insemination procedures and including medications, the number of cycles and their timing, and the total motile sperm count after washing.
The amount of motile sperm injected into the uterus is another crucial element influencing IUI success. As a result, IUI media/sperm wash is a crucial step in determining the overall IUI procedure's outcome.
IVF clinics are leading the market for intrauterine insemination devices due to the increasing preference of patients to seek treatment at these clinics. This has led to the expansion of the IVF services industry and the need for more fertility specialists.
The availability of superior medical diagnostic equipment and kits is one of the primary reasons why most people prefer to seek treatment at IVF clinics. Additionally, the availability of highly skilled medical professionals with extensive treatment experience is expected to contribute to the high market share of IVF clinics in the coming years. As a result, IVF clinics are expected to remain dominant players in the market for intrauterine insemination devices.
Leading players in the market are primarily focused on expanding their geographical presence and product offerings. This approach helps market participants to diversify their product portfolio and increase their market penetration. Consequently, these companies have grown their revenue share in the global intrauterine insemination devices market.
By expanding their geographical reach, leading players can tap into the growing demand for intrauterine insemination devices in emerging markets while enhancing their product offerings to help them meet their customers' diverse needs. As a result, market leaders are well-positioned to maintain their dominance in the intrauterine insemination devices market in the coming years.
A few examples of the key strategies followed by the manufacturers are
The United States and China dominate the global market.
Cooper Surgical and Cook Medical are the key players in the global market.
IVF clinic is capturing high revenue in the global market.
The market is estimated to secure a valuation of USD 40.5 million in 2023.
The market is estimated to reach USD 57.5 million by 2033.
1. Executive Summary | Intrauterine Insemination Devices Market 2. Market Overview 3. Market Background 4. Global Market Analysis 2018 to 2022 and Forecast, 2023 to 2033 5. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Product 5.1. IUI Catheters 5.2. IUI Media/Sperm Wash 6. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By End User 6.1. Hospitals 6.2. IVF Centres & Clinics 7. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Region 7.1. North America 7.2. Latin America 7.3. Europe 7.4. South Asia 7.5. East Asia 7.6. Oceania 7.7. MEA 8. North America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 9. Latin America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 10. Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 11. South Asia Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 12. East Asia Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 13. Oceania Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 14. MEA Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 15. Key Countries Market Analysis 16. Market Structure Analysis 17. Competition Analysis 17.1. Kitazato Corporation 17.2. Gynotec B.V. 17.3. Rocket Medical plc. 17.4. CooperSurgical, Inc. 17.5. Cook Group Inc. 17.6. Prince Medical SAS 17.7. Surgimedik Healthcare India Private Limited 17.8. MedGyn Products, Inc. 17.9. MediTech Devices Pvt. Ltd. 17.10. Biorad Medisys Pvt. Ltd. 18. Assumptions & Acronyms Used 19. Research Methodology
Explore Healthcare Insights
View Reports
Intrauterine Insemination Devices Market
